The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy (Q82255367)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Toshinori Nakayama

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

H Kidoya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

N Kunii

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

F Muramatsu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Y Okamoto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

N Takakura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

31 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

3254-3264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22037214%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2011.489

15 January 2020

exact match

0 references

cites work

Tumorigenesis and the angiogenic switch

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Out of air is not out of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Apelin increases contractility in failing cardiac muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Angiogenic inhibitors: a new therapeutic strategy in oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Endothelial-pericyte interactions in angiogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Anticancer strategies involving the vasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Engineering lymphocyte subsets: tools, trials and tribulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Retardation of retinal vascular development in apelin-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Apelin is a novel angiogenic factor in retinal endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Molecular properties of apelin: tissue distribution and receptor binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

The emerging role of adipokines as mediators of inflammation and immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Transcriptomes of purified gastric ECL and parietal cells: identification of a novel pathway regulating acid secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Pathology: cancer cells compress intratumour vessels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Genes that distinguish physiological and pathological angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Valpha14 NKT cell-mediated anti-tumor responses and their clinical application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Apelin is a potent activator of tumour neoangiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Taking dendritic cells into medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

A role for hematopoietic stem cells in promoting angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489

Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.489